Cargando…
Cost-Effectiveness of Influenza Vaccination Strategies in Adults: Older Adults Aged ≥65 Years, Adults Aged 50–64 Years, and At-Risk Adults Aged 19–64 Years
The high disease burden of influenza in elderly and chronically ill adults may be due to the suboptimal effectiveness and mismatch of the conventional trivalent influenza vaccine (TIV). This study evaluated the cost-effectiveness of quadrivalent (QIV), adjuvanted trivalent (ATIV), and high-dose quad...
Autores principales: | Choi, Min Joo, Shin, Gyeongseon, Kang, Daewon, Lim, Jae-Ok, Kim, Yun-Kyung, Choi, Won Suk, Yun, Jae-Won, Noh, Ji Yun, Song, Joon Young, Kim, Woo Joo, Choi, Sang-Eun, Cheong, Hee Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955502/ https://www.ncbi.nlm.nih.gov/pubmed/35335077 http://dx.doi.org/10.3390/vaccines10030445 |
Ejemplares similares
-
Severity of Daytime Sleepiness and Parkinsonian-Like Symptoms in Korean Adults Aged 50–64 Years
por: Shin, Chol, et al.
Publicado: (2022) -
Factors affecting influenza vaccination in adults aged 50-64 years with high-risk chronic diseases in South Korea
por: Jang, Hyeongap, et al.
Publicado: (2019) -
Modelling the influenza disease burden in people aged 50–64 and ≥65 years in Australia
por: Moa, Aye M., et al.
Publicado: (2021) -
Evaluation of Riboflavin Intakes and Status of 20–64-Year-Old Adults in South Korea
por: Choi, Ji Young, et al.
Publicado: (2014) -
Burden of severe illness associated with laboratory confirmed influenza in adults aged 50–64 years: A rapid review
por: Kim, Dong Kyu, et al.
Publicado: (2022)